文献速递慢阻肺

个体化呼吸困难干预可改善晚期慢阻肺患者结局

Individualized breathlessness interventions may improve outcomes in patients with advanced COPD.
PubMed 文献 · Respirology · 2018-05-15

6周后, Numerical Rating Scale评估的呼吸困难严重程度出现临床显著改善,合并焦虑/抑郁患者CRQ-SAS各领域也显著改善,患者报告干预高度有用且可接受。

要点

  • 个体化呼吸困难干预在严重慢阻肺伴难治性呼吸困难患者中可行且可接受。
  • 6周时 Numerical Rating Scale 评估的呼吸困难严重程度出现临床显著改善。
  • 合并焦虑/抑郁患者 CRQ-SAS 各领域也显著改善。

核心结论

  • 个体化呼吸困难干预在严重慢阻肺伴难治性呼吸困难患者中首次显示呼吸困难评分临床显著降低,且患者接受度高。

研究设计与样本

  • 干预包括个体化呼吸困难计划、信息手册、呼吸困难教育和手持风扇;基线和6周时使用经验证的呼吸困难、生活质量和焦虑/抑郁问卷评估,主要结局为呼吸困难评分变化。
  • 部分患者参加结构化电话访谈以定性评估干预。

主要发现

  • 平均改良医学研究理事会呼吸困难量表评分为3.5。
  • 焦虑和抑郁常见,分别见于38%和35%的参与者。
  • 6周时 Numerical Rating Scale 评估的呼吸困难严重程度出现临床显著改善。
  • 合并焦虑/抑郁亚组在 CRQ-SAS 所有领域也显著改善。
  • 患者报告干预高度有用且可接受。

临床怎么用

  • 对严重慢阻肺伴难治性呼吸困难患者,可考虑提供个体化呼吸困难干预组合(计划、教育、信息手册、手持风扇)。
  • 干预可能同时改善合并焦虑/抑郁患者的呼吸困难相关生活质量,但需注意该研究为可行性研究。

局限性

  • 随访时间短(6周)。
  • 单中心三级整合呼吸与姑息服务人群,外推性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Many patients with advanced COPD experience refractory breathlessness and individualized breathlessness interventions may improve management of this complex symptom. The aims of this study were to develop, implement and assess the efficacy of a breathlessness intervention for patients with COPD and refractory breathlessness and to evaluate patient acceptability. METHODS: An individualized breathlessness plan, information leaflets, breathlessness education and a hand-held fan were offered to consecutive patients with severe COPD and refractory breathlessness attending a tertiary integrated respiratory and palliative care service. Validated dyspnoea, quality of life and anxiety/depression questionnaires were administered at baseline and after 6 weeks, with change in dyspnoea scores being the primary outcome measure. A subset of patients participated in a structured telephone interview to qualitatively assess the intervention. RESULTS: Twenty-six patients with severe COPD (mean forced expiratory volume in 1 s (FEV1 ) 38%) were included, with a mean age of 74 years. Mean modified Medical Research Council Breathlessness Scale score was 3.5. Anxiety and depression were common, being present in 38% and 35% of participants. At 6 weeks, there was a clinically significant improvement in breathlessness severity as measured by the Numerical Rating Scale. The subset of patients with anxiety/depression also saw significant improvement in all domains of the Self-Administered Standardized Chronic Respiratory Questionnaire (CRQ-SAS). Patients reported that the intervention was highly useful and acceptable. CONCLUSION: This feasibility study of individualized breathlessness interventions in patients with severe COPD and refractory breathlessness is the first to demonstrate a clinically significant reduction in dyspnoea scores, with high levels of patient acceptability.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Qian MYY, Politis J, Thompson M, et al. Individualized breathlessness interventions may improve outcomes in patients with advanced COPD. Respirology. 2018. PMID: 29763515. doi:10.1111/resp.13324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。